Similar articles

• The immunomodulatory effect of extracorporeal therapies in sepsis: a reconciliation of three theories.

  Ronco C. Ronco C. Int J Artif Organs. 2007 Oct;30(10):855-7. doi: 10.1177/039139880703001001. Int J Artif Organs. 2007. PMID: 17992645 No abstract available.
• Improvement of immune dysfunction in patients with severe acute pancreatitis by high-volume hemofiltration: a preliminary report.

  Gong D, Zhang P, Ji D, Chen Z, Li W, Li J, Li L, Liu Z. Gong D, et al. Int J Artif Organs. 2010 Jan;33(1):22-9. Int J Artif Organs. 2010. PMID: 20162528 Clinical Trial.
• Hemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timing.

  Bouman CS, Oudemans-van Straaten HM, Schultz MJ, Vroom MB. Bouman CS, et al. J Crit Care. 2007 Mar;22(1):1-12. doi: 10.1016/j.jcrc.2006.05.002. Epub 2007 Jan 31. J Crit Care. 2007. PMID: 17371737 Review.
• Sorbents in acute renal failure and the systemic inflammatory response syndrome.

  Winchester JF, Kellum JA, Ronco C, Brady JA, Quartararo PJ, Salsberg JA, Levin NW. Winchester JF, et al. Blood Purif. 2003;21(1):79-84. doi: 10.1159/000067860. Blood Purif. 2003. PMID: 12566666 Review.
• Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis.

  Yekebas EF, Eisenberger CF, Ohnesorge H, Saalmüller A, Elsner HA, Engelhardt M, Gillesen A, Meins J, The M, Strate T, Busch C, Knoefel WT, Bloechle C, Izbicki JR. Yekebas EF, et al. Crit Care Med. 2001 Jul;29(7):1423-30. doi: 10.1097/00003246-200107000-00021. Crit Care Med. 2001. PMID: 11445702